Yalçın Gizem Yağmur, Dünya Cansu Polat, Yeni Kübra, Kürtüncü Murat, Tulek Zeliha, Gündüz Tuncay, Eraksoy Mefküre
From the Institute of Graduate Studies, Istanbul University-Cerrahpasa, Istanbul, Turkey.
Istanbul University Faculty of Nursing, Istanbul, Turkey.
Int J MS Care. 2024 Jul 22;26(Q3):194-198. doi: 10.7224/1537-2073.2023-056. eCollection 2024 May.
We aimed to evaluate the validity and reliability of the Turkish version of the Patient-Reported Impact of Spasticity Measure (PRISM-TR).
Expert opinions and the forward-back translation method were used for linguistic validation. Cronbach α and test-retest analysis were performed for reliability analysis. Correlations between the PRISM-TR and the Modified Ashworth Scale (MAS), the Numerical Rating Scale (NRS), and the Expanded Disability Status Scale (EDSS) were assessed.
A total of 206 individuals with multiple sclerosis (MS; 139 women; mean age, 47.7 ± 11.3 years; mean EDSS score, 5.2 ± 1.5) who had not had a relapse in the previous 3 months were included in the study. Test-retest correlation coefficients were high for all subdimensions of the scale (0.95-0.99). All Cronbach α values for the PRISM-TR subdimensions, except for Positive Impact, were likewise quite high (0.85-0.94). PRISM-TR subscale scores were correlated with MAS, NRS, and EDSS scores ( < .001).
PRISM-TR is a valid and reliable scale for use with Turkish individuals with MS. It is simple to use in the clinic and can be helpful in detecting patients' spasticity early in the disease course.
我们旨在评估痉挛性疾病患者报告影响量表土耳其语版（PRISM - TR）的有效性和可靠性。
采用专家意见和正反翻译法进行语言验证。进行Cronbach α分析和重测分析以评估可靠性。评估PRISM - TR与改良Ashworth量表（MAS）、数字评定量表（NRS）和扩展残疾状态量表（EDSS）之间的相关性。
共有206例过去3个月内未复发的多发性硬化症（MS）患者（139名女性；平均年龄47.7±11.3岁；平均EDSS评分5.2±1.5）纳入本研究。该量表所有子维度的重测相关系数均较高（0.95 - 0.99）。除积极影响维度外，PRISM - TR各子维度的所有Cronbach α值同样相当高（0.85 - .94）。PRISM - TR子量表得分与MAS、NRS和EDSS得分相关（P < .001）。
PRISM - TR是用于土耳其MS患者的有效且可靠的量表。它在临床中使用简便，有助于在疾病进程早期检测患者的痉挛情况。
